Dr. Paul Steinhardt is the Albert Einstein Professor in Science, Professor in the Department of Physics, Professor in the Department of Astrophysical Sciences, and Director of the Princeton Center for Theoretical Sciences. In addition, Paul is author of the popular science book Endless Universe: Beyond the Big Bang and the recently released book The Second Kind of Impossible: The Extraordinary Quest for a New Form of Matter. Paul is a theoretical physicist whose areas of study range from the nature of particles to the origins of the universe. He uses the known laws of nature to unravel some of the many secrets of nature that remain. His goal is to understand why things are the way they are and to discover connections between seemingly unrelated phenomena. In his free time, Paul enjoys hanging out with his four kids and his grandchild. Lately, he has also become fond of attending opera performances and hiking. Paul received his B.S. in physics from the California Institute of Technology (Caltech) and his M.A. and Ph.D. degrees in physics from Harvard University. Afterwards, Paul was a Junior Fellow in the Harvard Society of Fellows. He served on the faculty at the University of Pennsylvania for about 17 years before joining the faculty at Princeton University. Paul has been recognized for his exceptional research as one of the recipients of the 2002 Dirac Medal from the International Centre for theoretical Physics, a recipient of the Oliver E. Buckley Prize of the American Physical Society, a recipient of the John Scott Award, and one of the recipients of the 2018 Aspen Italia Prize. He is a Fellow of the American Physical Society and a Member of the National Academy of Sciences. Paul was also named a Sloan Fellow, a Guggenheim Fellow, the Simons Fellow in Theoretical Physics, a Radcliffe Institute Fellow at Harvard University, a Moore Fellow at Caltech, and a Caltech Distinguished Alumnus. In our interview Paul shared more about his life and science.

Direct download: 486_Paul_Steinhardt_Final.mp3
Category:general -- posted at: 3:00am EDT

Dr. Carla Finkielstein is an Associate Professor of Biological Sciences within the Biocomplexity Institute of Virginia Tech. She is also Director of the Integrated Cellular Response Laboratory at Virginia Tech, a Member of the Executive Committee of the Susan G. Komen Blue Ridge Board, and past member of the Board of Directors of the Virginia Breast Cancer Foundation. In the lab, Carla is interested in understanding the mechanisms cells use to measure time to regulate cell division. Evidence supports that people with circadian disorders have a higher incidence of cancer. Carla hypothesizes that cancer may occur when the clocks within cells don’t function properly. In these cases, the clocks may signal to the cell to divide too frequently. Carla’s goal is to understand how this process occurs so that we can fix the issue, detect the problem early to provide treatment, or prevent it from happening. Carla’s favorite hobby is cooking. She loves making new and creative dishes that bring together different colors, flavors, and taste profiles. Cooking is relaxing for her, and it’s fun to share dishes she creates with her friends and family. In addition, Carla enjoys reading a wide variety of books about history. Carla received her B.S. and Ph.D. both in Molecular Biology from the University of Buenos Aires in Argentina. Afterwards, she worked as a Research Associate at the Howard Hughes Medical Institute at the University of Colorado Health Sciences Center. Carla then conducted further postdoctoral research at the University of Colorado Health Sciences Center before joining the faculty at Virginia Tech. Carla has been recognized for her research accomplishments with the L. Chely Award for Best PhD Thesis, a Howard Hughes Institute Fellowship for Research, an American Heart Association Postdoctoral Fellowship, the Karin Noss Scholarship for Research Advocacy in Breast Cancer, the Susan G. Komen Award for Junior Investigators, and a National Science Foundation CAREER Award. In our interview Carla shared more about her life and science.

Direct download: 485_Carla_Finkielstein_Final.mp3
Category:general -- posted at: 3:00am EDT

Dr. Todd Zankel is co-founder and Chief Scientific Officer of Mercaptor Discoveries, Inc., a biotech company focused on developing molecules to treat brain injury and degeneration. Todd studies chemistry and molecular biology to develop new drugs to treat diseases of the central nervous system and brain. The molecules they are working on now help reduce side effects by making drugs only active in the parts of the body they are supposed to target. When he’s not working, Todd likes to read non-science books and take his dog for walks in the hills and woods near his house. Todd received his B.A. in Chemistry from Reed College and his Ph.D. in Chemistry from Columbia University. Afterwards, he accepted a position as an NIH postdoctoral fellow at the Plant Gene Expression Center in Berkeley, California as well as the Chemistry Department of ETH in Zurich, Switzerland. Todd then worked for BioMarin Pharmaceutical for about eight years. Before co-founding Mercaptor Discoveries, Todd co-founded Raptor Pharmaceuticals in 2006, acting as Chief Scientific Officer and head of discovery research until 2016 when the company was acquired. In our interview, Todd shared more about his life and science.

Direct download: 484_PBTS_Todd_Zankel_Final.mp3
Category:general -- posted at: 3:00am EDT

Dr. Michael Fox is an Associate Professor of Neurology at the Harvard University Medical School and Director of the Laboratory for Brain Network Imaging and Modulation. In addition, Mike is Associate Director of the Berenson-Allen Center for Noninvasive Brain Stimulation, Co-Director of the Beth Israel Deaconess Medical Center Deep Brain Stimulation Program, Assistant Neuroscientist at Massachusetts General Hospital, and a practicing clinical neurologist at the Beth Israel Deaconess Medical Center. In Mike’s research, he uses wiring diagrams of the human brain to try to make sense of brain problems and help patients. In the clinic, Mike treats patients with movement disorders like tremor and Parkinson’s disease using deep brain stimulation. He also uses noninvasive brain stimulation to treat people with psychiatric conditions like depression. When Mike isn’t doing research in his lab or working with patients in the clinic, he loves spending time with his wife and two daughters. They enjoy hiking and having fun outdoors together. He received his bachelor’s degree in Electrical Engineering from The Ohio State University, and he was awarded his MD and PhD from Washington University in St. Louis. Afterwards, Mike completed a medical internship at Barnes Jewish Hospital in St. Louis. Next, he completed his Neurology Residency and Movement Disorders Fellowship at Massachusetts General Hospital and Brigham and Women’s Hospital in Boston before becoming a faculty member with the Beth Israel Deaconess Medical Center and Harvard Medical School. Mike is the recipient of the inaugural Trailblazer Prize for Clinician-Scientists from the Foundation for the National Institutes of Health. In our interview, Mike tells us more about his life and science.

Direct download: 483_Mike_Fox_Final.mp3
Category:general -- posted at: 3:00am EDT






January 2019
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31